Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Tags: AIDS, antiretroviral, Atripla®, Emtriva®, HIV, nucleoside reverse transcriptase inhibitor, Stribild®, Truvada®
BASi Method Number SAP.767
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
